GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivesto AB (OSTO:VIVE) » Definitions » ROC (Joel Greenblatt) %

Vivesto AB (OSTO:VIVE) ROC (Joel Greenblatt) %

: -575.49% (As of Sep. 2023)
View and export this data going back to 2005. Start your Free Trial

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Vivesto AB's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -575.49%.

The historical rank and industry rank for Vivesto AB's ROC (Joel Greenblatt) % or its related term are showing as below:

OSTO:VIVE' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -2369.14   Med: -582.97   Max: -152.06
Current: -2359.35

During the past 13 years, Vivesto AB's highest ROC (Joel Greenblatt) % was -152.06%. The lowest was -2369.14%. And the median was -582.97%.

OSTO:VIVE's ROC (Joel Greenblatt) % is ranked worse than
96.62% of 1065 companies
in the Drug Manufacturers industry
Industry Median: 8.03 vs OSTO:VIVE: -2359.35

Vivesto AB's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -10.80% per year.


Vivesto AB ROC (Joel Greenblatt) % Historical Data

The historical data trend for Vivesto AB's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Array ( [0] => - [1] => - [2] => - [3] => - [4] => - [5] => -623.70 [6] => -1,005.21 [7] => -152.06 [8] => -560.34 [9] => -2,369.14 )
Vivesto AB Annual Data
Trend Apr13 Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Dec21 Dec22
ROC (Joel Greenblatt) %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -623.70 -1,005.21 -152.06 -560.34 -2,369.14

Vivesto AB Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
ROC (Joel Greenblatt) % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,098.25 -6,777.10 -638.97 -936.67 -575.49

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vivesto AB's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivesto AB ROC (Joel Greenblatt) % Distribution

For the Drug Manufacturers industry and Healthcare sector, Vivesto AB's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Vivesto AB's ROC (Joel Greenblatt) % falls into.



Vivesto AB ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.805 + 0 + 1.4210854715202E-14) - (4.766 + 0 + 18.392)
=-21.353

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.361 + 0 + 0) - (3.481 + 0 + 12.782)
=-15.902

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Vivesto AB for the quarter that ended in Sep. 2023 can be restated as:

ROC (Joel Greenblatt) %(Q: Sep. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2023  Q: Sep. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-62.74/( ( (11.557 + max(-21.353, 0)) + (10.247 + max(-15.902, 0)) )/ 2 )
=-62.74/( ( 11.557 + 10.247 )/ 2 )
=-62.74/10.902
=-575.49 %

Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vivesto AB  (OSTO:VIVE) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Vivesto AB ROC (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Vivesto AB's ROC (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vivesto AB (OSTO:VIVE) Business Description

Traded in Other Exchanges
Address
Gustav III:s Boulevard 46, 5th Floor, Solna, SWE, SE-169 73
Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.